TWST — Twist Bioscience Share News
0.000.00%
- $9.58bn
- $9.41bn
- $376.57m
U.S. STOCKS ON THE MOVE-Intel, Guardant, Ventas
Twist falls on larger-than-expected quarterly loss
Brief: Scorpion Capital Says Remain Short Twist Bioscience - X Post
Twist Bioscience Corp reports results for the quarter ended in June - Earnings Summary
Brief: Twist Bioscience Q3 Revenue USD 81.464 Million Vs. IBES Estimate USD 77.4 Million
Brief: Twist Bioscience Announces Clinical Progression of Pure Biologics’ Antibody Candidate Discovered Using Twist’s Antibody Libraries
Brief: Twist Bioscience Launches Synthetic RNA Control for H5N1 Influenza A
U.S. RESEARCH ROUNDUP-Avidity Biosciences, Broadcom, Cara Therapeutics
Twist Bioscience Corp reports results for the quarter ended in March - Earnings Summary
Brief: Twist Bioscience Q2 Revenue USD 75.302 Million Vs. IBES Estimate USD 70.7 Million
Twist Bioscience Corp expected to post a loss of 82 cents a share - Earnings Preview
Brief: Twist Bioscience Corp Announces Inducement Grants Under Nasdaq Listing Rule
Brief: Twist Bioscience Launches cfDNA Library Preparation Kit for Liquid Biopsy Applications
Brief: Twist Bioscience And Element Biosciences Collaborate On Exome Sequencing Solutions For AVITI System
Brief: Twist Bioscience Unveils Differentiated Ultra High-Throughput Library Preparation Solution At AGBT
Twist Bioscience Corp reports results for the quarter ended in December - Earnings Summary
U.S. STOCKS ON THE MOVE-Twist Bioscience, Hartford Financial
Twist Bioscience climbs after raising 2024 revenue forecast
Brief: Twist Bioscience Reports First Quarter 2024 Financial Results